TEL AVIV, Israel and BETHESDA, Maryland, Jan. 27, 2020 /PRNewswire/PRESS RELEASE — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that in a series of tests conducted at the company’s High Through-put Screening (HTS) facility in Israel, it has been shown that the cannabinoids CBC (cannabichromene) and... Read more

Cannabis sativa L. still holds many secrets. But, one compound at a time, scientists are beginning to decipher its complex code. In addition to increased interest in studying the hundreds of minor cannabinoids and terpenes the plant is capable of producing, researchers have also begun to examine the pharmacological... Read more

The hemp market continues to settle as farmers look to the 2020 season. As U.S. growers learn from lessons they picked up in previous years, and as more growers get into the game, the national and international markets will shake out and begin to look more like a commodities... Read more